Sharing research data increases reusability, reduces waste, supports reproducibility and promotes innovation. In medical research, sharing data also promotes transparency and access to information relevant to patient care.
While important advancements have been made in data sharing by regulators, the pharmaceutical industry and academic publishers, several barriers remain. Some of these barriers stem from concerns about data privacy and patient safety, but others are related to the need for confidence in sharing, which can be improved through agreed standards and systems for reuse of research data, including the application of FAIR (findable, accessible, interoperable, and reusable) principles and the overarching principle of “as open as possible, as closed as necessary”.
Medical writers, who are key links between the pharmaceutical and publishing industries, can contribute to making pharma publication data FAIRer. They also have an important role in educating others about the path to more findable, accessible, interoperable, and reusable data.
Medical Writing. 2022;31(4)38-43. https://doi.org/10.56012/efip1000
Editor-in-Chief
Co-Editors
Managing Editor
Victoria White
Associate Editors
Section Editors
Biotechnology
Digital Communication
EMWA News
Gained in Translation
Getting Your Foot in the Door
Good Writing Practice
In the Bookstores
Manuscript Writing
Medical Communications/Writing for Patients
Medical Devices
My First Medical Writing
News from the EMA
Out on Our Own
Pharmacovigilance
Regulatory Matters
Regulatory Public Disclosure
Teaching Medical Writing
The Crofter: Sustainable Communications
Veterinary Writing
Editors Emeritus
Lay out Designer
Chris Monk